Pinnacle Wealth Planning Services’s MapLight Therapeutics MPLT Stock Holding History

Pinnacle Wealth Planning Services’s Portfolio MPLT Stock Details MPLT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$45.3K	Buy	+1,265	New	+$36.4K	﹤0.01%	1341

Other funds holding MPLT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

MSWMA

Market Street Wealth Management Advisors Indianapolis, Indiana $703M AUM 16.2% 1-Year Est. Return

MPW

MA Private Wealth San Carlos, California $671M AUM 23.37% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Pinnacle Wealth Planning Services's MPLT Position: Q2 2026 in Review

Pinnacle Wealth Planning Services opened a new position in MapLight Therapeutics (MPLT) in Q2 2026: 1,265 shares worth $45.3K. The stake represents ﹤0.01% of the portfolio and ranks #1341 among its holdings.

25 funds tracked by Wall St. Rank hold MPLT as of Q2 2026.

Pinnacle Wealth Planning Services held 1,265 shares of MapLight Therapeutics worth $45.3K as of Q2 2026.
MapLight Therapeutics was a new Pinnacle Wealth Planning Services position in Q2 2026.
MapLight Therapeutics made up ﹤0.01% of Pinnacle Wealth Planning Services's portfolio in Q2 2026, its #1341 holding.
25 funds tracked by Wall St. Rank held MapLight Therapeutics as of Q2 2026.

Based on Pinnacle Wealth Planning Services's 13F filing for Q2 2026, filed 7 Aug 2026.